Tapentadol hydrochloride: a novel analgesic
SJA-Saudi Journal of Anaesthesia. 2013; 7 (3): 322-326
em Inglês
| IMEMR
| ID: emr-130459
ABSTRACT
Tapentadol is a novel, centrally acting analgesic with dual mechanism of action, combining mu-opioid receptor agonism with noradrenaline reuptake inhibition in the same molecule. It has an improved side effect profile when compared to opioids and nonsteroidal anti-inflammatory drugs. The dual mechanism of action makes Tapentadol a useful analgesic to treat acute, chronic, and neuropathic pain
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Fenóis
/
Analgésicos
Idioma:
Inglês
Revista:
Saudi J. Anaesth.
Ano de publicação:
2013
Similares
MEDLINE
...
LILACS
LIS